⌘K
Loading ticker…
Revolution Medicines, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, Revolution Medicines, Inc. Common Stock (RVMD) has a 3-month relative strength percentile of 96 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 95. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 4.5%, relative volume 2.89×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 96, Market Stance is mixed at 47, A/D rating A
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
RVMD is in a stage 2 uptrend, week 11. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: 20.4% / 84.8%.
No attention data for this ticker yet — it joins the daily scan once a baseline builds.
RVMD is held by 9 ETFs as of Mar 2026. Top owner: VTI at 0.03% weight, $582M notional. Top 3 carry $1.2B.
Top 9 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.03% | $582M |
| VBVanguard Small Cap ETF | 0.26% | $422M |
| VBKVanguard Small-Cap Growth ETF | 0.61% | $236M |
| VXFVanguard Extended Market ETF | 0.24% | $197M |
| XBIState Street SPDR S&P Biotech ETF | 1.11% | $83M |
| IWRiShares Russell Midcap ETF | 0.13% | $63M |
| IWDiShares Russell 1000 Value ETF | 0.05% | $38M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.03% | $22M |
| IWBiShares Russell 1000 ETF | 0.03% | $12M |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | RVMD Jan avg: 7.23% median: 5.23% win: 50% σ: 11.92% n: 4 2022-04-12 → 2026-05-29 | RVMD Feb avg: 1.60% median: 2.65% win: 75% σ: 5.24% n: 4 2022-04-12 → 2026-05-29 | RVMD Mar avg: -6.90% median: -8.94% win: 25% σ: 12.33% n: 4 2022-04-12 → 2026-05-29 | RVMD Apr avg: 14.26% median: 14.20% win: 80% σ: 22.67% n: 5 2022-04-12 → 2026-05-29 | RVMD May avg: 0.16% median: 2.82% win: 60% σ: 9.50% n: 5 2022-04-12 → 2026-05-29 | RVMD Jun avg: 4.18% median: 4.28% win: 75% σ: 9.08% n: 4 2022-04-12 → 2026-05-29 (current) | RVMD Jul avg: 8.24% median: 8.61% win: 75% σ: 9.94% n: 4 2022-04-12 → 2026-05-29 | RVMD Aug avg: 4.23% median: -2.36% win: 50% σ: 17.33% n: 4 2022-04-12 → 2026-05-29 | RVMD Sep avg: 1.38% median: 0.53% win: 50% σ: 17.64% n: 4 2022-04-12 → 2026-05-29 | RVMD Oct avg: 4.56% median: 10.36% win: 75% σ: 24.04% n: 4 2022-04-12 → 2026-05-29 | RVMD Nov avg: 18.64% median: 17.13% win: 100% σ: 9.98% n: 4 2022-04-12 → 2026-05-29 | RVMD Dec avg: 0.49% median: 1.70% win: 75% σ: 19.38% n: 4 2022-04-12 → 2026-05-29 |